|
Volumn 75, Issue 3, 2010, Pages 615-618
|
Primary Signet-ring Cell Carcinoma of the Urinary Bladder
|
Author keywords
[No Author keywords available]
|
Indexed keywords
5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR;
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CARCINOEMBRYONIC ANTIGEN;
ADULT;
AGED;
ANOREXIA;
ANURIA;
ARTICLE;
BLADDER CARCINOMA;
BLADDER WALL;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL ASSESSMENT;
COMPUTER ASSISTED TOMOGRAPHY;
CYSTECTOMY;
DATA BASE;
FEMALE;
FOLLOW UP;
HUMAN;
HYDRONEPHROSIS;
INFORMATION RETRIEVAL;
LEG EDEMA;
LUNG EMBOLISM;
MALE;
METASTASIS;
MULTIMODALITY CANCER THERAPY;
MULTIPLE CYCLE TREATMENT;
MULTIVARIATE ANALYSIS;
NEPHROSTOMY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OVERALL SURVIVAL;
PARAAORTIC LYMPH NODE;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN BLOOD LEVEL;
SIGNET RING CARCINOMA;
THICKNESS;
TREATMENT DURATION;
TREATMENT RESPONSE;
ADULT;
AGED;
CARCINOMA, SIGNET RING CELL;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
URINARY BLADDER NEOPLASMS;
|
EID: 77649189827
PISSN: 00904295
EISSN: 15279995
Source Type: Journal
DOI: 10.1016/j.urology.2009.06.065 Document Type: Article |
Times cited : (31)
|
References (6)
|